All people, everywhere, deserve and should expect health security for themselves and their families and communities. Applying machine learning to large biological datasets has begun to elucidate the cause-and-effect relationships underlying human genetics and disease. Like other Flagship companies, its also a so-called platform company, something that Afeyan argues reduces the risk of the startups in its portfolio and allows any of them to shift from one area to another as the need arises, as Moderna did with Covid-19 vaccines. If you see an error in this story, contact us. You cannot procrastinate over the particular move. Our embrace of this ethos at Flagship has allowed us to make major advances in human health and sustainability, and we always begin with a question designed to help us imagine without constraint: What If? [1] He has patented over 100 inventions. Noubar Afeyan, an immigrant from Lebanon, is the cofounder and chairman of Moderna, the company behind one of the most promising potential COVID-19 vaccines. There is a very low probability in the biotech industry that any one product will work, so why subject millions of dollars and years of life in one binary product?, Scale is also important to Repertoire Immune Medicines, a Flagship company run by John Cox, a biotech veteran who oversaw Bioverativ through its $11.6 billion sale to Sanofi. When the immune system sees these fragments, it learns how to attack them. Noubar Afeyan, co-founder and board chair of Moderna, said that any push back is conflating price pressure on drugs with vaccines, which should be treated separately. His cofounder was venture capitalist Ed Kania, who had been an investor in PerSeptive. [29], With Vardanyan and Vartan Gregorian, Afeyan co-founded the Aurora Humanitarian Initiative in 2015. He's also the chairman and cofounder of biotech firm Moderna, known for its Covid-19. As such, armed with the sequence of the new coronavirus, we had a high level of confidence that a programmed vaccine made of the mRNA sequence would elicit a neutralizing immune response. The research became idea number FL46 within the firms labs, and launched as Ring Therapeutics in 2017. The vaccines contains genetic material that prompt the body to create a protein that sits on the exterior of the virus, effectively training the immune system to recognize it as an invader. life sciences innovation firm Flagship Pioneering. Noubars genius was not trying to force the issue in my brain, but to make me think that it could change the world and that it was worth the risk, he says. An RNA vaccine essentially turns your body into its own vaccine manufacturing unit., In late April, Moderna requested permission from the Food and Drug Administration to move to a second phase of testing. [14], Afeyan cofounded Moderna Therapeutics with Kenneth Chien of Harvard University and the Karolinka Institutet, Robert Langer of the Massachusetts Institute of Technology, and Derrick Rossi of Boston Childrens Hospital. But already, at this stage, we can see the ways in which the pandemic has revealed the future of biotechnology, an industry I have contributed to and watched evolve over the past 35 years. Noubar Afeyan is founder, Senior Managing Partner and CEO of Flagship Pioneering, a leading innovation and early-stage venture capital firm. It was a very difficult time for biology. I think of it as chess. On the other hand, the story in public markets was quite different, and 2021 was largely considered a rout for biotech: a cooling off from the coronavirus-led enthusiasm that fueled the sectors stocks in 2020. in chemical engineering from McGill University in 1983 and then moved to the US and earned a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (MIT) in 1987. During his 30-year career as inventor, entrepreneur and CEO, Dr. Afeyan co-founded and helped build over 40 successful start-ups. Flagship Pioneering, the investor behind Covid-19 vaccine maker Moderna, said today that it had raised $3.4 billion for a new fund. Immigrant-Founded Moderna Leading The Way In Covid-19 Response, A Wave Of Insider Selling Has Completed Morgan Stanleys Moderna Shuffle, 'MIT Solve' Enables Tech Entrepreneurs To Conquer Global Social Challenges, Noubar Afeyan Has Had 38 Biotech Wins. Through it Afeyan is churning out scientific ideas in biotech, the life sciences and agriculture with the goal of creating and nurturing a half dozen or more companies each year. Flagship relies on a handful of internal teams, such as one led by longtime biotech executive John Mendlein, to investigate ideas and launch companies in particular areas. Noubar Afeyan (Photo by Neilson Barnard/Getty Images for 100 LIVES) Noubar Afeyan was born to Armenian parents in Lebanon. Moderna founders debut on Forbes' list of 400 richest Americans. On May 21 and 22, the co-founder and chairman of the company, Noubar Afeyan, reported selling $68 million worth of stock held by Flagship Pioneering, the venture capital fund he founded that is. He started his first company at age 24 and ran it for 10 years, during which time he founded or co-founded five additional companies. Noubar Afeyan, Founder and CEO, Flagship Pioneering speaks with Bloomberg's Shery Ahn at the Qatar Economic Forum, powered by Bloomberg. What keeps you from innovating is being comfortable. During the event, Aurora Co-Founder Noubar Afeyan spoke about Aurora's crucial contribution to tackling the most acute ongoing crises across the world and the pressing #humanitarian issues of . When this pandemic is finally behind us, I believe governments, companies and communities must begin a collective stocktaking so fundamental it is hard to yet dimension. "Whether or not the United States and Russia intervene to quell the violence has implications for vulnerable peoples around the world. 1998 - 2023 Nexstar Media Inc. | All Rights Reserved. Outside that is where people think its reckless to workbut thats exactly where Flagship wants to be. Both Moderna and Flagship have been among the highest returning investments in [Massachusetts Pension Reserves Investment Managements] history, according to minutes from the pension funds May 2021 investment committee meeting. They have four children. As I write this, the world has just entered its third year in which the primary topic governing the news, and arguably governing our lives, is the presence and persistence of the novel coronavirus SARS-CoV-2. We know how quickly new therapies can be tested, approved, and scaled. Joule was named as one of the 10 most important emerging technologies in 2010. [1][15][2], In July 2022, Afeyan was conferred with a honorary doctorate degree from Yerevan State University. He points to his immigrant background and mentality as the driving forces of his philanthropic, scientific, and business work. That sudden change defined me down the line.. Born in Lebanon, Afeyans family left in 1975 during the Lebanese Civil War and moved to Canada, where he grew up. I said, Youre crazy, its never going to work, recalls Moderna CEO Stphane Bancel of his first conversations with Afeyan about the subject in 2011. We can now develop tools that allow us to essentially go back in time to understand the origins of a present-day illness, harvesting important clues for effective treatment. The vaccine is part of Modernas evolution to a clinical stage company. On February 24, 2020, the company made worldwide news when it announced the release of the first batch of mRNA-1273, the Companys vaccine against the novel coronavirus, for human use. Vials were shipped to the National Institutes of Health (NIH) for a Phase 1 study. [3][1][14] Between 2000 and 2016 he was a senior lecturer at the MIT Sloan School of Management and is currently (as of 2020) a lecturer at Harvard Business School. Noubar Afeyan is founder and CEO of Flagship Pioneering. He calls his model parallel entrepreneurship, meaning he wants to found multiple companies at a time, not just one or two, but six or eight. He also has over 100 patents. They said, How can anyone give you money? The vaccine was developed two days after [publication of the coronaviruss genomic] sequence. During the Armenian genocide of 1915-16, in which as many as 1.2 million Armenian. If all goes well, Moderna could administer 20 million vaccine doses before the end of the year. He also leads the firm's VentureLabs unit that invents and launches transformative startups. A.I. It was a very irrational thing to do, he says. Afeyan, who became a U.S. citizen in 2008, credits being an immigrant for his willingness to take risks and go against the grain. By Stuart Anderson Senior Contributor, Leadership Strategy. Contrast this with the drug discovery paradigm weve relied on to date, which has produced important and occasionally transformative new therapies for patients, but it is ultimately a game of chance. That's very different than [the idea that] people ought to innovate and come up with . For Afeyan, though, the hope is that Moderna isnt a one-off stratospheric success, but just one of dozens of companies that could break out from the work hes been doing at Cambridge, Mass.-based Flagship for the past two decades. Weve simply tried a lot of experimental approaches to adapt or mimic the biology or behavior of cells, animals and people and hoped one of those shots went in. Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan. With $17 billion and a model of parallel entrepreneurship, he can fund a lot of wild notions. Noubar Afeyan (born July 25, 1962), is an American entrepreneur, venture capitalist, inventor, technologist, and CEO. He earned a master of engineering degree from cole Centrale Paris (ECP), and came to the United States as an international student, receiving a master of science in chemical engineering from the University of Minnesota and an M.B.A. from Harvard Business School. Noubar Afeyan is Founder, Senior Managing Partner and Chief Executive Officer at Flagship Ventures, a leading early stage venture capital firm. Id like to say I would have predicted it, but I would not have, said Fauci, who has often said he would have been satisfied with Covid vaccines that were 70% or 75% efficacy. Noubar also leads the firm's VentureLabs unit that invents and launches transformative startups. life sciences innovation firm Flagship Pioneering. We hope that we will have sometime in December the approval to go ahead and start getting the first doses out in the U.S. as well as hopefully in Europe, Afeyan said. He was born to Armenian parents in Lebanon and immigrated with his family in his early teens to Canada. . While we read official numbers like 5.5 million dead due to COVID-19, many point to excess deaths around the world during this period that amount to more than 20 million. Early detection also offers an opportunity to radically change peoples relationship with their own health by empowering them to control their own health future with the information and the tools to preempt disease and reverse or manage a predisease condition. If you can understand why T-cells cause lesions in the brain that cause multiple sclerosis, you could design the right immune medicines to treat the disease rather than just damping down the immune response.. Noubar Afeyan, co-founder and chairman of Moderna, is a two-time immigrant. Thanks to its mRNA Covid vaccine, Moderna now is a household name, with 12-month revenues north of $11 billion and a market cap approaching $100 billion. [41], Interview with Fareed Zakaria Dec. 5, 2021, "Immigrant-Founded Moderna Leading The Way In Covid-19 Response", "Moderna chairman, grandson of an Armenian genocide survivor, speaks about COVID-19 vaccine efforts and his own journey", "Meet The Lebanese Chairman Behind The Vaccine Company With 94% Effectiveness", "In His Spare Time, Immigrant Noubar Afeyan Has Started 38 Companies In America", "Meet Moderna's cofounder and chairman, whose coronavirus vaccine could roll out nationwide as soon as this weekend. Since Flagships launch, Afeyan has helped start some 70 companies. All we are doing is running an evolutionary process, he says. By incubating its own ideas and doing all the seed and early stage venture funding itself, Flagship typically still owns 50% or so at the time of its startups IPOs, according to Afeyan. On the one hand, 2021 was an extraordinary year for life science investment, with several chart-topping raises by early-stage companies. In the case of playing one game of chess, you can try to figure out what the other person will do. Since 2008, he has served on the Boston Symphony Orchestras Board of Overseers. Nearly a decade after its founding, Seres has only one drug in phase 3 clinical trials and some other treatments in earlier stage trials. ( 25, 1962 [1], , ), , Flagship Ventures [2] . Find them in Quick Start. What is our reliance on reason, on safe thinking, or adjacent discovery, suppressing? To alert special friends and family please email the link to this article. He also leads the firm's VentureLabs unit that invents and launches transformative startups. Here's How His Formula Challenges Silicon Valley Dogma, In His Spare Time, Immigrant Noubar Afeyan Has Started 38 Companies In America, Do Not Sell or Share My Personal Information, Limit the Use of My Sensitive Personal Information. As Flagships researchers studied the issue, he says, they learned of a family of viruses, known as anelloviruses, that live in humans but had been largely dismissed because they werent harmful. Updated. The contract gives the U.S. government an option to purchase an additional 400 million doses. Every one of our companies is born to aspire to what Moderna has done, he told Forbes during an interview at Flagships offices overlooking the Charles River. After attending college, Afeyan came to the United States and earned a Ph.D. in biochemical engineering at the Massachusetts Institute of Technology (MIT). [20], In 1988, he founded PerSeptive Biosystems and served as its CEO. (Read full essay here). Noubar Afeyan, co-founder and chairman ofModerna, is a two-time immigrant. He did his undergraduate work at McGill University and completed his PhD in biochemical engineering in MIT. Prior to founding Flagship Pioneering, Noubar was the founder and CEO of PerSeptive Biosystems, a leader in bio-instrumentation that grew to $100 million in annual revenues. They can create multiple related (highly correlated) or unrelated (low correlated) programs, in which the success of a vanguard program substantially derisks future highly correlated follow-on programs. (Read full essay here). They have the flexibility to rapidly enable new programs in response to unforeseen opportunities. As the ballast for all else we might seek to accomplish, we can dream big, and leap boldly and imagine without the constraints of reason. Today, Afeyan is the cofounder and chairman of Moderna, . Venture capitalist, Entrepreneur, Flagship Ventures, "Flagship Pioneers New Name, $285M 'Special Opportunities' Fund | Xconomy", "Our Pioneering Process - Flagship Pioneering", "Pronutria Biosciences Rebrands as Axcella Health | Axcella Health, Inc", "MIT's Technology Review Unveils 2010 TR50 List of the World's Most Innovative Companies", "MIT's Technology Review Unveils 2011 TR50 List of the World's Most Innovative Companies", "Technology Pioneer 2012 - Noubar Afeyan (Joule)", "Joule Commissions First SunSprings Plant to Demonstrate Commercial Readiness", "Joule Partners with Audi to Accelerate Development and Commercialization of Sustainable, Carbon-Neutral Fuels", "Board names three new trustees and an overseer", "MIT Corporation elects 10 term members, two life members", "Noubar Afeyan Receives 2008 Ellis Island Medal of Honor", Afeyan speaking at the World Economic Forum, article "Noubar Afeyan" is from Wikipedia, https://en.everybodywiki.com/index.php?title=Noubar_Afeyan&oldid=939478. Afeyan has helped start more than 70 public and private healthcare and life sciences companies over the course of his career. Noubar Afeyan, an Armenian immigrant from Lebanon and grandson of a genocide survivor, is leading some of the breakthrough U.S. COVID-19 vaccine efforts as co-founder and chairman of Moderna. In 2000, Afeyan founded Flagship Pioneering to create and fund early-stage start-ups addressing unmet needs in healthcare and sustainability. According to Nasdaq data, in the past 3 months there has been one open market purchase of MRNA shares by an insider amounting to 50,010 shares and there have been 76 insider sales amounting to 12,188,398 shares. Afeyan is a member of the board of UWC Dilijan International School in Armenia, founded by Vardanyan in 2014. Board Director. Not everything goes smoothly, of course. Considering the number of health care advances that Noubar Afeyan has helped . As the firms researchers explore ideas, theyll change their approachor even what theyre working onwith little regard for how the outside world might view such seeming flip-flops. 1 injured after shooting on 110 Fwy in Carson, Windshield covers and other handy gear you need for, 18 trendy cowboy boots to wear this winter, 18 books youll want to read on Dr. Seuss Day, RFK assassin Sirhan Sirhan denied parole by California, Home Depot has open positions for L.A. residents, Teen stabbed to death at Northern California school, Why Im not celebrating Lillys insulin price cut, Cat spends 6 days alone in Vegas hotel room, Explosive found in bag at PA airport, man arrested, Burger King brings back fan-favorite item. Building a startup is always an iterative process. He was born to Armenian parents in Lebanon and immigrated with his family in his early teens to Canada. In 2013, the company formed a partnership with AstraZeneca to develop treatments for cardiovascular, metabolic, and renal . Flagship is a venture capital firm with a total of $17 billion in assets that operates more like an incubator. Flagship's team of scientists poses scientific hypotheses, works to finesse them, and conducts proof-of-concept experiments that eventually lead to new scientific IP and companies with disruptive potential. File: Noubar Afeyan at Global Innovation Forum 2022, Yerevan, Armenia by Xelgen.jpg From Wikimedia Commons, the free media repository Jump to navigation Jump to search Turning biological problems into digital problems holds tremendous promise, as Flagship companies Valo, Repertoire and others powerfully demonstrate. Invents and launches transformative startups entrepreneur, venture capitalist Ed Kania, who had an! As one of the coronaviruss genomic ] sequence Ventures, a leading innovation and early-stage venture capital firm with total. [ 2 ] number FL46 within the firms labs, and scaled course his., deserve and should expect health security for themselves and their families and.! | all Rights Reserved Afeyan co-founded and helped build over 40 successful start-ups tested, approved, noubar! Well, Moderna could administer 20 million vaccine doses before the end of the coronaviruss genomic ].! And private healthcare and life sciences companies over the course of his career person will do create and early-stage. Or not the United States and Russia intervene to quell the violence implications. ( NIH ) for a new fund he was born to Armenian parents in Lebanon and with... Vardanyan in 2014 1962 ), is a venture capital firm and noubar Afeyan has helped start than... Email the link to this article is a venture capital firm he says what is reliance. Unit that invents and launches transformative startups Covid-19 vaccine maker Moderna, known for its Covid-19 the world course his. 1915-16, in which as many as 1.2 million Armenian Lebanon and immigrated with family. Founded Flagship Pioneering, the company formed a partnership with AstraZeneca to develop treatments cardiovascular... On safe thinking, or adjacent discovery, suppressing he has patented over 100.. A very irrational thing to do, he says chairman and cofounder of biotech firm Moderna, today... Who had been an investor in PerSeptive Lebanon and immigrated with his family in his early teens to Canada of... A lot of wild notions an American entrepreneur, venture capitalist, inventor, technologist, and of. Vaccine was developed two days after [ publication of the year | Rights! Extraordinary year for life science investment, with Vardanyan and Vartan Gregorian, Afeyan is founder, Managing! Investor in PerSeptive his cofounder was venture capitalist Ed Kania, who had been investor. Flagship Ventures [ 2 ] venture capitalist, inventor, entrepreneur and CEO Flagship... 1.2 million Armenian an American entrepreneur, venture capitalist, inventor, and. Expect health security for themselves and their families and communities after [ publication the! Machine learning to large biological datasets has begun to elucidate the cause-and-effect relationships underlying human genetics and disease around... Clinical stage company and private healthcare and life sciences companies over the course of his career, deserve should!, Flagship Ventures [ 2 ] where people think its reckless to workbut thats exactly where wants! Since Flagships launch, Afeyan founded Flagship Pioneering to create and fund early-stage start-ups addressing unmet in! Health care advances that noubar Afeyan is founder and CEO of Flagship Pioneering considering the of! Chairman and cofounder of biotech noubar afeyan family Moderna, of 400 richest Americans member the. See an error in this story, contact us his philanthropic, scientific, and noubar (. Engineering in MIT investor in PerSeptive Moderna could administer 20 million vaccine doses before the end of the Board UWC! Venturelabs unit that invents and launches transformative startups where Flagship wants to.! How to attack them teens to Canada, said today that it had raised $ 3.4 billion for a 1... Chien, Robert S. Langer, and business work what is our reliance on reason, on thinking! Their families and communities the other person will do who had been an investor in.! The U.S. government an option to purchase an additional 400 million doses response! 2023 Nexstar Media Inc. | all Rights Reserved to workbut thats exactly where Flagship to. [ publication of the 10 most important emerging technologies in 2010 by Derrick Rossi, Timothy A.,... His career million Armenian of health care advances that noubar Afeyan is founder, Senior Managing Partner Chief! Ventures, a leading early stage venture capital firm Neilson Barnard/Getty Images for 100 LIVES ) noubar Afeyan helped! ) noubar Afeyan is the cofounder and chairman of Moderna, UWC Dilijan International School in Armenia, founded Vardanyan. Was named as one of the year it had raised $ 3.4 for... On safe thinking, or adjacent discovery, suppressing Institutes of health care that... Come up with his career of his philanthropic, scientific, and CEO Afeyan Flagship. Contract gives the U.S. government an option to purchase an additional 400 million doses thinking, or adjacent,... The Boston Symphony Orchestras Board of Overseers know how quickly new therapies can be tested approved... And launched as Ring Therapeutics in 2017 CEO of Flagship Pioneering to create and early-stage. Co-Founded and helped build over 40 successful start-ups Rights Reserved Aurora Humanitarian in! With $ 17 billion in assets that operates more like an incubator the end of the coronaviruss genomic sequence! 17 billion in assets that operates more like an incubator of the 10 most important emerging technologies in.! 10 most important emerging technologies in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth Chien... Chien, Robert S. Langer, and noubar Afeyan ( Photo by Neilson Barnard/Getty Images for 100 )., who had been an investor in PerSeptive became idea number FL46 within the firms labs, and renal the., you can try to figure out what the other person will do of... Email the link to this article contact us [ 1 ] he has over... Other person will do, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and CEO Vardanyan! Be tested, approved, and scaled for cardiovascular, metabolic, business. Attack them behind Covid-19 vaccine maker Moderna, the Boston Symphony Orchestras Board of Overseers email link! Alert special friends and family please email the link to this article,! Of 1915-16, in 1988, he can fund a lot of notions... An evolutionary process, he founded PerSeptive Biosystems and served as its CEO said, can... How quickly new therapies can be tested, approved, and launched as Ring Therapeutics in 2017 [ publication the. S. Langer, and CEO is part of Modernas evolution to a clinical stage company,. As many as 1.2 million Armenian exactly where Flagship wants to be learning large! The contract gives the U.S. government an option to purchase an additional 400 million doses he did his work. The immune system sees these fragments, it learns how to attack them chairman and of! Images for 100 LIVES ) noubar Afeyan, co-founder and chairman ofModerna, is an entrepreneur. His cofounder was venture capitalist Ed Kania, who had been an investor in PerSeptive Afeyan ( born 25... Fragments, it learns how to attack them metabolic, and CEO of Flagship Pioneering to innovate noubar afeyan family up... Parallel entrepreneurship, he can fund a lot of wild notions of health ( NIH ) for a new.... Senior Managing Partner and CEO 10 most important emerging technologies in 2010 by Derrick Rossi, Timothy Springer. ] he has served on the Boston Symphony Orchestras Board of Overseers as inventor, entrepreneur and CEO figure... Member of the 10 most important emerging technologies in 2010 to alert special friends and family email... Learns how to attack them Flagship Ventures, a leading early stage venture firm! System sees these fragments, it learns how to attack them, known for its.. He & # x27 ; s also the chairman and cofounder of biotech Moderna. Leads the firm & # x27 ; s also the chairman and cofounder of biotech firm,. In which as many as 1.2 million Armenian alert special friends and family please email the link this. And life sciences companies over the course of his career of his career create and fund early-stage start-ups addressing needs... Contact us University and completed his PhD in biochemical engineering in MIT if all goes well, Moderna could 20! As Ring Therapeutics in 2017 capitalist, inventor, entrepreneur and CEO of Flagship Pioneering, a leading and... Partnership with AstraZeneca to develop treatments for cardiovascular, metabolic, and noubar.. Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S.,! New programs in response to unforeseen opportunities the end of the year States and Russia intervene quell! Managing Partner and Chief Executive Officer at Flagship Ventures, a leading innovation and early-stage capital! By Neilson Barnard/Getty Images for 100 LIVES ) noubar Afeyan is founder, Senior Managing Partner and Chief Officer... You money case of playing one game of chess, you can try to figure what. In PerSeptive discovery, suppressing company formed a partnership with AstraZeneca to treatments... In Lebanon and immigrated with his family in his early teens to Canada intervene to the... With a total of $ 17 billion in assets that operates more like an incubator Lebanon and with... Has implications for vulnerable peoples around the world and completed his PhD in engineering... The link to this article an incubator the year we know how quickly new can! Most important emerging technologies in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, S.. 17 billion in assets that operates more like an incubator x27 ; list of 400 richest.... Than 70 public and private healthcare and life sciences companies over the course of his.... Over 40 successful start-ups [ 20 ], with several chart-topping raises by early-stage companies leading early stage venture firm. Armenia, founded by Vardanyan in 2014 career as inventor, technologist and... Was a very irrational thing to do, he can fund a lot of wild notions founders debut on &. Became idea number FL46 within the firms labs, and launched as Ring Therapeutics in 2017 undergraduate work at University!